PDS Biotechnology (Germany) Market Value
| EU6 Stock | EUR 1.64 0.10 5.75% |
| Symbol | PDS |
PDS Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PDS Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PDS Biotechnology.
| 01/13/2024 |
| 01/07/2025 |
If you would invest 0.00 in PDS Biotechnology on January 13, 2024 and sell it all today you would earn a total of 0.00 from holding PDS Biotechnology Corp or generate 0.0% return on investment in PDS Biotechnology over 360 days. PDS Biotechnology is related to or competes with RYMAN HEALTHCAR, FEMALE HEALTH, RCI Hospitality, Siemens Healthineers, Grand Canyon, Xinhua Winshare, and British American. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer ... More
PDS Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PDS Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PDS Biotechnology Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 38.41 | |||
| Value At Risk | (8.81) | |||
| Potential Upside | 6.43 |
PDS Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PDS Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PDS Biotechnology's standard deviation. In reality, there are many statistical measures that can use PDS Biotechnology historical prices to predict the future PDS Biotechnology's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | 53.09 |
PDS Biotechnology Corp Backtested Returns
PDS Biotechnology Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.2, which implies the firm had a -0.2% return per unit of standard deviation over the last 3 months. PDS Biotechnology Corp exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PDS Biotechnology's Market Risk Adjusted Performance of 53.1, risk adjusted performance of (0.07), and Coefficient Of Variation of (976.18) to confirm the risk estimate we provide. The company holds a Beta of -0.0114, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PDS Biotechnology are expected to decrease at a much lower rate. During the bear market, PDS Biotechnology is likely to outperform the market. At this point, PDS Biotechnology Corp has a negative expected return of -0.97%. Please make sure to check PDS Biotechnology's total risk alpha, potential upside, kurtosis, as well as the relationship between the treynor ratio and skewness , to decide if PDS Biotechnology Corp performance from the past will be repeated at future time.
Auto-correlation | 0.50 |
Modest predictability
PDS Biotechnology Corp has modest predictability. Overlapping area represents the amount of predictability between PDS Biotechnology time series from 13th of January 2024 to 11th of July 2024 and 11th of July 2024 to 7th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PDS Biotechnology Corp price movement. The serial correlation of 0.5 indicates that about 50.0% of current PDS Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.33 |
PDS Biotechnology Corp lagged returns against current returns
Autocorrelation, which is PDS Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PDS Biotechnology's stock expected returns. We can calculate the autocorrelation of PDS Biotechnology returns to help us make a trade decision. For example, suppose you find that PDS Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PDS Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PDS Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PDS Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PDS Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
PDS Biotechnology Lagged Returns
When evaluating PDS Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PDS Biotechnology stock have on its future price. PDS Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PDS Biotechnology autocorrelation shows the relationship between PDS Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in PDS Biotechnology Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out PDS Biotechnology Correlation, PDS Biotechnology Volatility and PDS Biotechnology Alpha and Beta module to complement your research on PDS Biotechnology. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
PDS Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.